Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
GlobeNewswire - Industry News on Pharmaceuticals
Get the latest updates from GlobeNewswire - Industry News on Pharmaceuticals directly as they happen.
Follow now 114 followers
Latest posts
Last updated about 1 hour ago
Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
about 1 hour ago
IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ...
SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC
about 2 hours ago
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq...
Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025
about 2 hours ago
Eledon to Host a Conference Call to Discuss Updated Data from the...
Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin
about 10 hours ago
– New patent enhances market position in Europe
NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025
about 10 hours ago
-- Pre-specified analysis shows obicetrapib significantly reduced absolute levels of plasma p-tau217...
SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease
about 10 hours ago
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq...
Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models
about 10 hours ago
-Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology...
Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress
about 11 hours ago
LONDON and PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM...
Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components
about 11 hours ago
Q2 2025 Highlights:
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
about 14 hours ago
CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ...
Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein
about 14 hours ago
Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025:
Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development
about 14 hours ago
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: